Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5412206
Reference Type
Journal Article
Title
Trochanteric fragility fractures Treatment using the cement-augmented proximal femoral nail antirotation
Author(s)
Neuerburg, C; Mehaffey, S; Gosch, M; Boecker, W; Blauth, M; Kammerlander, C
Year
2016
Is Peer Reviewed?
1
Journal
Operative Orthopaedie und Traumatologie
ISSN:
0934-6694
Volume
28
Issue
3
Page Numbers
164-176
Language
English
PMID
27245659
DOI
10.1007/s00064-016-0449-5
Web of Science Id
WOS:000378002200002
Abstract
OBJECTIVE:
Use of standardized cement augmentation of the proximal femur nail antirotation (PFNA) for the treatment of trochanteric fragility fractures, which are associated with high morbidity and mortality, to achieve safer conditions for immediate full weight-bearing and mobilization, thus, improving preservation of function and independency of orthogeriatric patients.
INDICATIONS:
Trochanteric fragility fractures (type 31-A1-3).
CONTRAINDICATIONS:
Ipsilateral arthritis of the hip, leakage of contrast agent into the hip joint, femoral neck fractures.
SURGICAL TECHNIQUE:
Reduction of the fracture on a fracture table if possible, or minimally invasive open reduction of the proximal femur, i. e., using collinear forceps if necessary. Positioning of guidewires for adjustment of the PFNA and the spiral blade, respectively. Exclusion of leakage of contrast agent and subsequent injection of TRAUMACEM™ V(+) into the femoral head-neck fragment via a trauma needle kit introduced into the spiral blade. Dynamic or static locking of the PFNA at the diaphyseal level.
POSTOPERATIVE MANAGEMENT:
Immediate mobilization of the patients with full weight-bearing and secondary prevention, such as osteoporosis management is necessary to avoid further fractures in the treatment of these patients.
RESULTS:
A total of 110 patients older than 65 years underwent the procedure. Of the 72 patients available for follow-up (average age 85.3 years), all fractures healed after an average of 15.3 months. No complications related with cement augmentation were observed. Approximately 60 % of patients achieved the mobility level prior to trauma.
Keywords
Weight-bearing; Hip fracture; Osteoporosis; Bone fractures; Elderly
Tags
PFAS
•
Additional PFAS (formerly XAgency)
•
PFAS 150
Literature Search August 2019
PubMed
Web of Science
Not prioritized for screening
Perfluorononanoic acid
•
PFNA
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity